These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17244112)

  • 1. The problem with Kt/V: dialysis dose should be normalized to metabolic rate not volume.
    Morton AR; Singer MA
    Semin Dial; 2007; 20(1):12-5. PubMed ID: 17244112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Kt calculation as a quality indicator of haemodialysis adequacy].
    Molina Núñez M; Roca Meroño S; de Alarcón Jiménez RM; García Hernández MA; Jimeno Griño C; Alvarez Fernández GM; Navarro Parreño MJ; Pérez Silva FM
    Nefrologia; 2010; 30(3):331-6. PubMed ID: 20514099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The monitoring of dialysis dose by ionic dialysance-based Kt reveals less dialysis adequacy than the Kt/V(UREA)-based measurement in critically ill patients with acute renal failure].
    Serra Cabañas N; Barros Freiría X; Garro Martínez J; Blasco Pelícano M; Maduell Canals F; Torras Rabasa A; Poch López de Briñas E
    Nefrologia; 2010; 30(2):232-5. PubMed ID: 20393623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dialysis adequacy and nutritional status of hemodialysis patients.
    Teixeira Nunes F; de Campos G; Xavier de Paula SM; Merhi VA; Portero-McLellan KC; da Motta DG; de Oliveira MR
    Hemodial Int; 2008 Jan; 12(1):45-51. PubMed ID: 18271840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface-area-normalized Kt/V: a method of rescaling dialysis dose to body surface area-implications for different-size patients by gender.
    Daugirdas JT; Depner TA; Greene T; Kuhlmann MK; Levin NW; Chertow GM; Rocco MV
    Semin Dial; 2008; 21(5):415-21. PubMed ID: 18945330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quest for V: body composition could determine dialysis dose.
    Sarkar SR; Kotanko P; Heymsfeld SB; Levin NW
    Semin Dial; 2007; 20(5):379-82. PubMed ID: 17897239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease severity adversely affects delivery of dialysis in acute renal failure.
    Schiffl H
    Nephron Clin Pract; 2007; 107(4):c163-9. PubMed ID: 17975323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revisiting the hemodialysis dose.
    Leypoldt JK; Cheung AK
    Semin Dial; 2006; 19(2):96-101. PubMed ID: 16551284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the ionic dialysance monitor on Kt measurement in hemodialysis.
    Maduell F; Vera M; Arias M; Serra N; Blasco M; Bergadá E; Fontsere N; Cases A; Campistol JM
    Am J Kidney Dis; 2008 Jul; 52(1):85-92. PubMed ID: 18455852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Which index to choose for quantification of the adequacy of filtration method in the hemodialysis patient?].
    Petitclerc T; Nour D; Jaudon MC; Jacobs C
    Nephrologie; 1992; 13(2):93-8. PubMed ID: 1608503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionic dialysance: principle and review of its clinical relevance for quantification of hemodialysis efficiency.
    Mercadal L; Ridel C; Petitclerc T
    Hemodial Int; 2005 Apr; 9(2):111-9. PubMed ID: 16191058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodialysis adequacy in children: urea kinetic modelling.
    Fischbach M
    EDTNA ERCA J; 1996; 22(4):15-8. PubMed ID: 10723341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target quantity for twice-a-week hemodialysis: the EKR (equivalent renal urea clearance) approach.
    Manotham K; Tiranathanagul K; Praditpornsilpa K; Eiam-Ong S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S79-85. PubMed ID: 17044458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons of Kt/V evaluated using an online method and calculated from urea measurements in patients on intermittent hemodialysis.
    Grzegorzewska AE; Banachowicz W
    Hemodial Int; 2006 Oct; 10 Suppl 2():S5-9. PubMed ID: 17022752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of dialysis dose during combination therapy with peritoneal dialysis and hemodialysis.
    Kawanishi H; Moriishi M; Tsuchiya S
    Adv Perit Dial; 2007; 23():135-9. PubMed ID: 17886620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of fractional urea clearance on survival of hemodialysis patients in relation to gender.
    Ferreira JC; de Andrade LG; Barretti P; Caramori JC; Balbi AL; Martin LC
    Ren Fail; 2008; 30(3):257-60. PubMed ID: 18350444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urea distribution volume calculated by ionic dialysance].
    Teruel JL; Merino JL; Fernández-Lucas M; Tenorio MT; Rivera M; Marcén R; Ortuño J
    Nefrologia; 2006; 26(1):121-7. PubMed ID: 16649433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Kt as control and follow-up of the dose at a hemodialysis unit].
    Maduell F; Vera M; Serra N; Collado S; Carrera M; Fernández A; Arias M; Blasco M; Burgadá E; Cases A; Campistol JM
    Nefrologia; 2008; 28(1):43-7. PubMed ID: 18336130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is a surrogate marker for optimal dialysis?
    Ishizaki M; Matsunaga T; Itagaki I
    Hemodial Int; 2007 Oct; 11(4):478-84. PubMed ID: 17922747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The urea [clearance x dialysis time] product (Kt) as an outcome-based measure of hemodialysis dose.
    Lowrie EG; Chertow GM; Lew NL; Lazarus JM; Owen WF
    Kidney Int; 1999 Aug; 56(2):729-37. PubMed ID: 10432415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.